Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals Market Cap : 1.786B for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.802B |
| November 13, 2026 | 1.888B |
| November 12, 2026 | 1.899B |
| November 11, 2026 | 1.962B |
| November 10, 2026 | 1.899B |
| November 09, 2026 | 1.876B |
| November 06, 2026 | 1.758B |
| November 05, 2026 | 1.690B |
| November 04, 2026 | 1.876B |
| November 03, 2026 | 1.865B |
| November 02, 2026 | 1.785B |
| October 30, 2026 | 1.821B |
| October 29, 2026 | 2.219B |
| October 28, 2026 | 2.272B |
| October 27, 2026 | 2.267B |
| October 26, 2026 | 2.196B |
| October 23, 2026 | 2.205B |
| October 22, 2026 | 2.217B |
| October 21, 2026 | 2.216B |
| October 20, 2026 | 2.184B |
| October 19, 2026 | 2.080B |
| October 16, 2026 | 1.867B |
| October 15, 2026 | 1.926B |
| October 14, 2026 | 1.846B |
| October 13, 2026 | 1.801B |
| Date | Value |
|---|---|
| October 12, 2026 | 1.837B |
| October 09, 2026 | 1.896B |
| October 08, 2026 | 1.903B |
| October 07, 2026 | 1.895B |
| October 06, 2026 | 1.891B |
| October 05, 2026 | 1.863B |
| October 02, 2026 | 1.895B |
| October 01, 2026 | 1.936B |
| September 30, 2026 | 1.982B |
| September 29, 2026 | 1.985B |
| September 28, 2026 | 1.992B |
| September 25, 2026 | 1.942B |
| September 24, 2026 | 1.961B |
| September 23, 2026 | 2.038B |
| September 22, 2026 | 2.084B |
| September 21, 2026 | 2.024B |
| September 18, 2026 | 1.971B |
| September 17, 2026 | 2.003B |
| September 16, 2026 | 1.964B |
| September 15, 2026 | 1.956B |
| September 14, 2026 | 1.980B |
| September 11, 2026 | 2.003B |
| September 10, 2026 | 2.005B |
| September 09, 2026 | 2.064B |
| September 08, 2026 | 2.000B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Protagonist Therapeutics, Inc. | 8.132B |
| Keros Therapeutics, Inc. | 224.48M |
| ACADIA Pharmaceuticals, Inc. | 3.163B |
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Anika Therapeutics, Inc. | 172.65M |
Market Cap Related Metrics
| PS Ratio | 12.53 |
| Price to Book Value | 1.824 |
| Price | 29.88 |
| Earnings Yield | -21.15% |